Skip to main content
. 2024 May 24;15(2):92791. doi: 10.4291/wjgp.v15.i2.92791

Figure 3.

Figure 3

Diversity of pathogenetic mechanisms leading to metabolic dysfunction-associated steatotic liver disease. MASLD: Metabolic dysfunction-associated steatotic liver disease; DNL: De novo lipogenesis.